Byk-Sangtec and Nichols to co-market analyser:
This article was originally published in Clinica
A new magnetic particle chemiluminescence immunoassay-based analyser, featuring a "unique bar-coded, ready-to-use, on-board reagent system", is to be co-marketed worldwide by Byk-Sangtec Diagnostica (Germany) and the Nichols Institute Diagnostics subsidiary of Corning Life Sciences (US). The fully automated random access immunoassay analyser, for clinical laboratories, is compatible with the reagent systems of either company (under the agreement they will market the device separately). The system can rapidly process statistical requests.